The TAM (Tyro3, Axl, and MerTK) family of receptor tyrosine kinases (RTKs) has recently been implicated in tumor growth, metastasis, and therapeutic resistance in breast cancer [19,20,21,22,23]. This evidence concerns the gene MERTK and breast carcinoma.